Nadzam D M
Indicator Development, Joint Commission on Accreditation of Healthcare Organizations, Chicago, IL 60611.
Am J Hosp Pharm. 1991 Sep;48(9):1925-30.
The development of indicators for monitoring medication use is described. The Joint Commission on Accreditation of Healthcare Organizations is establishing a national database for use in measuring performance. Initially, indicators were developed for specialties or clinical departments and for disease entities or procedures; now, indicators for key functions that cross departmental and specialty lines, such as medication use, are under development. An interdisciplinary core group constructed a medication-use flow chart depicting prescribing, dispensing, administering, and monitoring patient response; systems management/control was recognized as a fifth component. Sixteen processes were identified for which indicators were developed. Proposed indicators are now being tested in a small number of hospitals. The indicator data will enable institutions to identify areas for improvement. Although the Joint Commission will not use indicator rates per se to determine accreditation, it will ask an institution to provide an interpretation of indicator data that differ markedly from previous data or data for comparable institutions and to review its strategy for analyzing the rates. Use of indicator data will enhance the accreditation process by allowing for ongoing monitoring of particular aspects of performance between onsite surveys.
本文描述了监测药物使用指标的制定情况。医疗保健机构认证联合委员会正在建立一个用于衡量绩效的全国性数据库。最初,指标是针对专科或临床科室以及疾病实体或诊疗程序制定的;现在,正在制定跨部门和专科领域的关键功能指标,如药物使用指标。一个跨学科核心小组构建了一个药物使用流程图,描述了处方开具、配药、给药以及监测患者反应的过程;系统管理/控制被视为第五个组成部分。确定了16个制定指标的流程。目前,提议的指标正在少数医院进行测试。指标数据将使机构能够确定改进领域。尽管联合委员会本身不会使用指标率来确定认证,但它会要求机构对明显不同于先前数据或可比机构数据的指标数据进行解释,并审查其分析这些比率的策略。通过在现场调查之间对绩效的特定方面进行持续监测,指标数据的使用将加强认证过程。